General

medicine

Global General Medicine Education Publishing Industry

New York, Nov. 16, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global General Medicine Education Publishing Industry” – https://www.reportlinker.com/p05960946/?utm_source=GNW
5 Billion by 2027, growing at aCAGR of 5.6% over the period 2020-2027. Electronic & Online Publishing, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Print Publishing segment is readjusted to a revised 5.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 8.5% CAGR

The General Medicine Education Publishing market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 8.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.We bring years of research experience to this 9th edition of our report. The 179-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Elsevier B.V.
  • John Wiley & Sons, Inc.
  • Kaplan, Inc.
  • Mcgraw-Hill Education, Inc.
  • Springer Nature Switzerland AG
  • Thieme Medical Publishers, Inc.
  • Wolters Kluwer

Read the full report: https://www.reportlinker.com/p05960946/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
General Medicine Education Publishing Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for General Medicine
Education Publishing by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027

Table 2: World Historic Review for General Medicine Education
Publishing by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 3: World 15-Year Perspective for General Medicine
Education Publishing by Geographic Region – Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Electronic &
Online Publishing by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027

Table 5: World

Read More
medicine

Global General Medicine Education Publishing Industry – Press Release

New York, Nov. 16, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global General Medicine Education Publishing Industry” – https://www.reportlinker.com/p05960946/?utm_source=GNW
5 Billion by 2027, growing at aCAGR of 5.6% over the period 2020-2027. Electronic & Online Publishing, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Print Publishing segment is readjusted to a revised 5.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 8.5% CAGR

The General Medicine Education Publishing market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 8.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.We bring years of research experience to this 9th edition of our report. The 179-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Elsevier B.V.
  • John Wiley & Sons, Inc.
  • Kaplan, Inc.
  • Mcgraw-Hill Education, Inc.
  • Springer Nature Switzerland AG
  • Thieme Medical Publishers, Inc.
  • Wolters Kluwer

Read the full report: https://www.reportlinker.com/p05960946/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
General Medicine Education Publishing Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for General Medicine
Education Publishing by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027

Table 2: World Historic Review for General Medicine Education
Publishing by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 3: World 15-Year Perspective for General Medicine
Education Publishing by Geographic Region – Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Electronic &
Online Publishing by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027

Table 5: World

Read More
health

John Elway, the football Hall of Famer and Denver Broncos general manager, has tested positive for the virus.

John Elway, the former Denver Broncos quarterback who is now the team’s general manager and president of football operations, has tested positive for the virus, along with the team’s president and chief executive, Joe Ellis, the team said in a statement on Tuesday.

Mr. Elway had been at UCHealth Training Center, the Broncos practice facility, on Monday morning, but left “after experiencing minor symptoms that he quickly brought to the attention of our medical staff,” the statement said. Mr. Elway retired in 1999 after winning two straight Super Bowl victories with the Broncos. He was inducted into the Pro Football Hall of Fame in 2004.

Mr. Ellis did not feel well on Sunday morning and watched Sunday’s game against the Los Angeles Chargers from home, the team said, and then worked from home on Monday.

The team said that both men were experiencing only mild symptoms and would continue to work from home in isolation.

“Based on a review of contact-tracing data with the league, we are confident these cases originated independently outside team facilities,” the team said, adding that the two men had “minimal close contacts,” none of whom were players or coaches.

“It’s certainly a concerning situation for us,” Dr. Allen Sills, the N.F.L.’s chief medical officer, said on Tuesday. “We know that there are areas of the country where it is spiking and increases vulnerability.” He added that the league had not seen positive cases on teams rise as quickly as in the general populace.

Colorado, which once looked like it had gotten a grip on the coronavirus, has slipped. Daily reports of new cases are soaring to record heights, and the number of patients hospitalized with Covid-19 has tripled since early September.

The Colorado Department of Public Health and Environment is now warning that hospitalizations in the state are likely to blast through the peaks of last April and could overwhelm the state’s intensive care units by January. The department estimated that one in every 219 people in Colorado is infectious.

“It’s really a very scary rise,” Dr. Jonathan Samet, the dean of the Colorado School of Public Health, said in an interview. “Clearly, Coloradans have lapsed.”

Source Article

Read More
health

General plans campaign to deliver coronavirus vaccine quickly

The Pentagon general spearheading President Trump’s drive to ensure a coronavirus vaccine gets to the American people in record time said Tuesday that Operation Warp Speed can only work if there is full buy-in from the public when the vaccine becomes available.

Army Gen. Gustave Perna, a military logistics specialist who got a shoutout from Mr. Trump himself at last week’s presidential debate, described his mission at a session organized by the conservative Heritage Foundation was “our world’s best scientists and doctors working beside the world’s best military with the support of American industry and academia.”

“It’s the collective effort that will ensure we’re successful. I’m proud to be a part of it,” Gen. Perna said.

Operation Warp Speed is pushing ahead in the face of an at times angry political debate over the government’s handling of the virus crisis and whether the urgency of the mission will affect the safety of the process.

Thousands of volunteers will be needed after pharmaceutical giants AstraZeneca and Johnson & Johnson announced this week they were restarting U.S. clinical trials on their coronavirus vaccine candidates following a temporary stand-down over possible safety issues. Officials at Operation Warp Speed — a public-private partnership to develop therapeutics and ultimately a vaccine for COVID-19 — said locating a large number of volunteers for the trials is absolutely crucial.

In the past, about 5,000 to 8,000 people agreed to take part in clinical trials, Dr. Matthew Hepburn, head of program’s vaccine development, told the Heritage gathering.

“Our standard has been 30,000 volunteers for our clinical trials. We want to gather as much safety information as we possibly can,” Dr. Hepburn said Tuesday. “We want to know if [the vaccine candidates] work. The more people you enroll, the sooner you’re going to be able to evaluate the effectiveness.”

Dr. Hepburn said biotech firm Moderna has already completed its Phase 3 clinical trials with more than 30,000 volunteers enrolled in the testing. The New York-based pharmaceutical company Pfizer has signed up more than 40,000 people to take part in currently ongoing testing.

“That shows me that over 60,000 Americans have decided to say, ‘I will volunteer. I don’t know if I’m going to receive the vaccine or if I receive a placebo. But I’m going to do my part,’” Dr. Hepburn said. “We’re very proud of the spirit of volunteerism that we see in America.”

Medical researchers will be keeping in contact with those who received the initial COVID-19 vaccine candidates.

“The people that are vaccinated in the clinical trial now, our intention is to follow them for up to two years so we can get a better idea on that critically important question of duration of protection,” Dr. Hepburn said.

Past campaigns against viruses such as smallpox, polio and the measles made it possible for researchers to move more quickly to the coronavirus finish line, officials said.

“These efforts have gone on for decades. We stand on the shoulder of giants,” Dr. Hepburn said. “There was massive progress

Read More
health

Philips and Singapore General Hospital (SGH) to establish Digital and Computational Pathology Center of Excellence

Digital pathology at Singapore General Hospital

October 23, 2020

  • SGH aims to develop the first fully digitized histopathology laboratory in ASEAN by expanding the use of Philips’ IntelliSite Pathology Solution, potentially increasing the productivity of existing staff by 7%

  • Philips Singapore and SGH will optimize digital pathology use to facilitate research in Artificial Intelligence (AI)

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a collaboration with Singapore General Hospital (SGH) to establish the Singapore General Hospital Digital and Computational Pathology Center of Excellence. The SGH Center of Excellence aims to advance pathology practice by implementing a fully digital histopathology workflow and deploying Artificial Intelligence (AI) to increase productivity and enhance patient care.

Located within SGH’s Division of Pathology, one of the largest pathology laboratories in ASEAN, the Center of Excellence aims to establish ASEAN’s first fully digitized histopathology laboratory by expanding its digital pathology capabilities for primary diagnosis, training, and R&D with the Philips IntelliSite Pathology Solution. Both SGH and Philips will also work closely on other diverse areas, including streamlining of the histopathology laboratory’s digital workflow.

As in other parts of the world, the demand for cancer diagnosis in Singapore is increasing while pathologists remain scarce. A recent study, conducted by SGH and Philips, revealed that full digitization of SGH’s histopathology laboratory will improve efficiency. It has the potential to enable time savings in the pathology workflow and allow the pathology department to increase its capacity by another 7% whilst retaining the same number of employees.

Through optimization of digital pathology at SGH, the hospital will be able to further its research in AI. AI-based tools can aid pathologists in diagnosing diseases such as cancer – the leading cause of mortality in Singapore [1] – and empower them to face the current challenges in pathology. The increasing number of cancer cases, an aging population, and rapid advances in personalized medicine have resulted in significant complexity of pathological diagnostics, adding to the workload of pathologists. AI will allow pathologists to focus more on challenging tasks and unusual cases that require a higher degree of expertise and skills.

“As healthcare becomes more complex and demanding, digitization has become a key enabler for the Hospital to provide better care for our patients and to be more efficient,” said Prof. Kenneth Kwek, Chief Executive Officer at SGH. “Digital pathology is an example of that. Our partnership with companies such as Philips, with its clinical and technical know-how, is important in helping us achieve our goal.”

“Digital pathology enhances the quality and efficiency of a histopathology laboratory,” said Diederik Zeven, General Manager, Health Systems, Philips ASEAN Pacific. “We are committed to partnering with leading healthcare institutions like Singapore General Hospital to bring the latest in precision diagnosis and AI capabilities to help them augment clinical quality, improving patient outcomes and thereby reducing the cost of care.”

Philips IntelliSite Pathology Solution enables pathologists to review and interpret digital images of surgical pathology

Read More
health

U.S. again tops 60K new COVID-19 cases; Surgeon General Jerome Adams rejects ‘herd immunity’

Oct. 21 (UPI) — U.S. Surgeon General Dr. Jerome Adams joined other top health experts Wednesday in opposing a dangerous “herd immunity” strategy, as the United States again added another 60,000 COVID-19 cases.

According to updated data from Johns Hopkins University, there were 60,300 new cases nationwide on Tuesday — the third time in the past week that the level has topped 60,000.

Deaths in the United States also increased on Tuesday, the data showed, to more than 900. Since the start of the pandemic, there have been 8.28 million cases and about 221,100 deaths nationwide.

Wednesday, Adams joined Dr. Antony Fauci and other top health officials in opposing a herd immunity strategy, which is purportedly being considered by the Trump administration. Adams said pursuing such a strategy, which effectively allows the coronavirus to spread unchecked, would result in an unacceptable death toll.

Adams tweeted that there’s no “example of a large-scale successful intentional infection-based herd immunity strategy” and warned that the course would “lead to many complications/deaths.”

The strategy reasons that letting the virus spread would infect large populations, who would then develop a natural immunity to COVID-19 and thereby reduce the number of people who can be infected afterward. Eventually, the theory goes, the virus would run into a dead end.

“Large numbers of people would need to be infected to achieve herd immunity without a vaccine,” Adams wrote, warning that such a path could “overwhelm” healthcare systems.

Fauci, director of the National Institute of Allergy and Infectious Diseases, rejected the idea of herd immunity last week, calling it “ridiculous” and “total nonsense.”

Most scientists say there would be no feasible way to isolate and protect vulnerable Americans who face a greater risk of death from COVID-19 in such a scenario.

Researchers at the University of Washington say a herd immunity strategy would likely lead to tens of thousands of additional deaths by the start of 2021.

Child cases have increased by almost 15% — 84,000 cases — in the first two weeks of October, according to an update from the American Academy of Pediatrics and Children’s Hospital Association.

Since the start of the crisis, about 740,000 children have tested positive in the United States — almost 11% of total cases, it said. The overall infection rate is 986 per 100,000 children.

Though severe illness and deaths still appear to be rare among children, the groups urged authorities to “provide detailed reports on COVID-19 cases, testing, hospitalizations and mortality by age and race/ethnicity so that the effects of COVID-19 on children’s health can be documented and monitored.”

The Centers for Disease Control and Prevention said Tuesday there have been about 300,000 deaths more than normal so far this year due to the pandemic.

In a typical year, the CDC said, there are about 1.9 million deaths from all causes between February and October. This year, COVID-19 has pushed that figure to near 2.2 million, an increase of 14.5%.

About 200,000 of the extra deaths may be attributed to

Read More
dentist

Dentist West Ryde, West Ryde Dental Clinic Offers General, Cosmetic, Orthodontic and Dental Implant Services in NSW – Press Release

Dentist West Ryde, West Ryde Dental Clinic Offers General, Cosmetic, Orthodontic and Dental Implant Services in NSW

A good dentist is one that will be willing to go all out to ensure that all of the needs of their patients are being addressed. That is exactly what patients get when they reach out to West Ryde Dental Clinic for their dental care and treatment needs.

West Ryde, NSW – There will only be a few options when choosing a family dentist. The whole process can be a challenging endeavor even for people that have been through it before.  It can be confusing to make the right decision, as the dentist will be depended on for the oral health care needs of the whole family. A good dentist is one that will be willing to go all out to ensure that all of the needs of their patients are being addressed. That is exactly what patients get when they reach out to West Ryde Dental Clinic for their dental care and treatment needs.

“We firmly believe prevention is key to a beautiful and healthy smile, and so we will do everything we can to minimise any barriers to visiting the dentist. To achieve this, we do not charge a gap payment from any health fund for preventative services, and this includes your 6 monthly check-ups, scale and cleans, check-up x-rays, intraoral photos, personalised treatment plan, and fluoride treatments. We also believe in early intervention orthopedic and orthodontic treatments, having a strong focus on maximising jaw development, to ensure ideal relationships are formed for the jaws,” said Dr Thomas Choi, the spokesperson for the dental clinic, regarding their unrivalled services.

The practice is dedicated to providing personalized dental care and treatment for the whole family. All of the dentists at West Ryde Dental Clinic have gone through extensive training and are graduates of some of the best Australian universities. The practice has also invested in continuous education to ensure that every team member is better equipped to address the needs of their patients.

For patients that are always busy during the week, the practice makes sure that there are available slots during the weekend so that high-quality dental care and treatment are available round the clock.

Patients can take advantage of the free and no-obligation consultation so that they’re aware of their oral health. Going to the dentist isn’t something that should be dreaded and that is why West Ryde Dental Clinic makes sure that patients are comfortable right from the moment that they walk through their office doors. Senior cardholders can expect a 10% discount on all dental services. The practice is open for patients of all ages and their sole goal is to provide a 100% satisfaction guarantee on the dental services that they provide.

West Ryde Dental Clinic takes pride in the fact that their dentists are members of the Australian Academy of Dento-Facial Aesthetics. Patients can rest easy knowing that they’re getting a dentist West Ryde that will help achieve a Hollywood smile.

The practice takes a preventive approach when it comes to dental care

Read More